PCI Pharma Services Executive and Leadership Team

Tom De Weerdt, the Chief Financial Officer at PCI Pharma Services, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, De Weerdt ensures robust financial health across the organization's United States and European locations. This leadership role involves managing capital allocation, optimizing investment strategies, and maintaining strong relationships with financial institutions. By analyzing market trends and economic indicators, the Chief Financial Officer guides the company's financial trajectory, supporting sustainable growth and profitability. De Weerdt's financial acumen is critical for resource management and driving operational efficiency throughout the company's integrated service offerings, from clinical trial supply to commercial manufacturing and packaging. Tom De Weerdt's strategic financial oversight underpins the company's ability to expand its global reach and service capabilities.

Gil Valadez, the Chief Operating Officer at PCI Pharma Services, directs the operational execution of the company's comprehensive service portfolio. Overseeing day-to-day activities across manufacturing, packaging, and distribution, Valadez ensures the efficient delivery of services to clients in the global healthcare industry. This leadership position involves optimizing production processes, managing supply chain logistics, and maintaining the highest standards of quality and compliance across facilities in the United States and Europe. By driving operational excellence, the Chief Operating Officer supports the company's mission to provide integrated solutions from formulation development to commercialization. Valadez's focus on operational efficiency is key to enhancing service delivery and expanding market reach. Gil Valadez's strategic management of operations is vital for the company's sustained growth and client satisfaction.

Laila Rubi, the Chief Operating Officer, Clinical Quality Documents at PCI Pharma Services, spearheads the management and integrity of all clinical quality documentation. Overseeing the meticulous creation, review, and archival of essential documents, Rubi ensures strict adherence to regulatory requirements and industry best practices across clinical trial supply services. This specialized role involves implementing robust quality management systems and driving process improvements to enhance document accuracy and accessibility. By maintaining the highest standards of clinical quality documentation, the Chief Operating Officer, Clinical Quality Documents supports the company's commitment to regulatory compliance and client trust. Rubi's dedication to quality assurance is paramount for the successful execution of clinical trial programs. Laila Rubi's leadership in clinical quality documentation reinforces PCI Pharma Services' reputation for reliability and excellence.

Alice Farley, the President at PCI Pharma Services, provides overarching strategic direction and leadership for the organization. Guiding the company's vision and growth initiatives, Farley ensures the continued delivery of integrated services to the global healthcare industry. This executive role involves fostering a culture of innovation, driving market expansion, and strengthening client relationships across all business units. By championing the company's core values, the President oversees the strategic alignment of services, including analytical services, formulation development, and commercial manufacturing. Farley's leadership is instrumental in navigating the complexities of the pharmaceutical sector and reinforcing PCI Pharma Services' position as a trusted partner. Alice Farley's strategic guidance is essential for the company's ongoing success and commitment to patient well-being.

Brian Keesee, the President, Clinical Trial Services at PCI Pharma Services, directs the comprehensive suite of services supporting global clinical trials. Overseeing operations from drug product development to packaging and distribution for investigational medicines, Keesee ensures the efficient and compliant execution of trial supply chains. This leadership role involves managing complex logistics, maintaining stringent quality standards, and fostering strong partnerships with pharmaceutical and biotechnology companies. By driving innovation and operational excellence within clinical trial services, the President, Clinical Trial Services directly contributes to accelerating drug development timelines. Keesee's expertise is critical for navigating the unique demands of the clinical trial landscape. Brian Keesee's dedicated leadership ensures the seamless delivery of critical support for advancing global health initiatives.

Halley Liu, the President at PCI Pharma Services, drives strategic initiatives and operational oversight across key business segments. Focusing on enhancing the company's integrated service offerings, Liu ensures alignment with market demands and client needs within the global healthcare industry. This executive position involves cultivating strategic partnerships, identifying new growth opportunities, and optimizing resource allocation to support expansion in the United States and Europe. By promoting a culture of continuous improvement, the President contributes to the company's ability to deliver exceptional value in areas such as clinical trial supply and commercial manufacturing. Liu's leadership is vital for maintaining PCI Pharma Services' competitive advantage and commitment to innovation. Halley Liu's strategic vision supports the company's mission to improve patient access to essential medicines.

Yann Ghafourzadeh, the President, Commercial Packaging Technology at PCI Pharma Services, leads the advancement and execution of innovative packaging solutions for commercial pharmaceutical products. Overseeing the development and implementation of cutting-edge packaging technologies, Ghafourzadeh ensures product integrity, patient safety, and market readiness. This critical role involves managing state-of-the-art packaging operations, driving efficiency, and maintaining compliance with global regulatory standards across facilities. By focusing on technological innovation in packaging, the President, Commercial Packaging Technology enhances the company's ability to serve the evolving needs of the pharmaceutical industry. Ghafourzadeh's expertise is crucial for delivering high-quality, secure, and compliant packaging solutions. Yann Ghafourzadeh's leadership in packaging technology strengthens PCI Pharma Services' comprehensive commercialization support.

Edward DePrimo, the Chief Information Officer at PCI Pharma Services, architects and executes the company's global technology strategy. Overseeing all IT infrastructure, cybersecurity, and digital transformation initiatives, DePrimo ensures seamless technological operations across all service areas, including analytical services, formulation development, and supply chain management. This critical role involves implementing advanced systems to enhance data security, operational efficiency, and client connectivity. By driving innovation in IT solutions, the Chief Information Officer supports the company's mission to provide integrated services to the global healthcare industry. DePrimo's leadership ensures that PCI Pharma Services leverages cutting-edge technology to maintain its competitive edge and deliver exceptional value to its partners. Edward DePrimo's vision for technology integration is fundamental to the company's operational excellence and future expansion.